Meta-Analysis of the Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Patients With Polycystic Ovary Syndrome

1Department of Endocrinology, the First Affiliated Hospital of Xinjiang Medical University, State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Urumqi, China 2Department of Endocrinology, Cao County People's Hospital of Shandong Province, Heze, China Supported by the fund project in the state key laboratory of the causes and control of high incidence diseases in Central Asia jointly established by the ministry and the province. Name of the fund: The role of TCF7L2/Wnt/GLP-1 signaling pathway and environmental factors in the pathogenesis of type 2 diabetes in Kazakhs (No.SKL-HIDCA-2019-15). The funding body had no role in the design of the study and collection, analysis, and interpretation of data and in writing the article. The authors have no conflicts of interest to declare. L.L. and S.-F.W. contributed equally to this study.